Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries U.S. appeals court upholds ruling that canceled Teva Copaxone patents By: Reuters: Company News October 12, 2018 at 10:10 AM EDT A U.S. appeals court on Friday upheld a ruling that canceled patents owned by Teva Pharmaceutical Industries Ltd on its blockbuster multiple sclerosis drug Copaxone. Read More >> Related Stocks: Mylan Teva Pharmaceutical Industries ADR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
U.S. appeals court upholds ruling that canceled Teva Copaxone patents By: Reuters: Company News October 12, 2018 at 10:10 AM EDT A U.S. appeals court on Friday upheld a ruling that canceled patents owned by Teva Pharmaceutical Industries Ltd on its blockbuster multiple sclerosis drug Copaxone. Read More >> Related Stocks: Mylan Teva Pharmaceutical Industries ADR